Delivery Order SPE2DB24D3013-SPE2DB26FFFYY
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 8, 2025, for Clonidine HCl ER 0.17 mg tablets (30-count supply) with a ceiling value of $1,491.84. This firm fixed-price, competitively awarded contract carries an ultimate completion date of September 9, 2025, and involves no set-aside designation. The delivery order represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $1,187.00. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract with performance executed from the contractor's Conshohocken, Pennsylvania location. The award is a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count packages) with a ceiling value of $10,418.83. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The contract specifies an ultimate completion date of October 24, 2025, and identifies AmerisourceBergen's Conshohocken, Pennsylvania location as the place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 7, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets (60-count units) with a ceiling value of $11,427.01. This firm fixed-price delivery order, with an ultimate completion date of June 9, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Clonidine HCL ER 0.1 mg tablets in a quantity of 60 count, with a ceiling value of $1,012.72. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and was awarded through open competition without a set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Clonidine HCl ER 0.1 mg tablets (60-count) on August 27, 2025, with a ceiling value of $4,493.28 and an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,292.85 for Clonidine HCL ER 0.1 mg tablets (60-count) with an ultimate completion date of October 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with federal medical procurement systems. The place of performance is the vendor's corporate office in...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,956,820 units of Clonidine HCl ER 0.1 mg tablets in 60-count packages. The $2,018.04 contract has a performance period through March 14, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,159.04 to AmerisourceBergen Drug Corp for the supply of Clonidine HCL ER 0.1 mg tablets (60-count) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitive award utilizes a firm fixed-price contract structure with no set-aside designation. The product will be delivered to the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Clonidine HCl ER 0.17 mg tablets. The contract has a ceiling value of $4,590.39 and a completion date of June 21, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFYYDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Clonidine HCL ER 0.17 mg tablets in 30-count packages. This is a firm fixed-price delivery order with a ceiling value of $2,858.49 and an ultimate completion date of October 30, 2025. The award was not set aside for any specific category and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products to support military healthcare systems and other government agencies. The company demonstrates extensive capability in fulfilling federal medication procurement requirements across multiple therapeutic domains through its established relationship with the Defense Logistics Agency. Clonidine HCL ER, a centrally acting alpha-2 adrenergic agonist commonly used for hypertension and other cardiovascular indications, represents the type of essential medication within AmerisourceBergen's portfolio that supports military and veteran healthcare operations. This delivery order exemplifies the company's role as a key supplier within the DLA's pharmaceutical supply chain serving the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 10/29/25 |